Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zofia Kachlik

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Journal of the European Academy of Dermatology and Venereology : JEADV|July 10, 2024
Comments on 'Characterization of patients with atopic dermatitis based on flare patterns and severity of disease: A Danish population-based study'Zofia Kachlik, Michał Walaszek, Michał Pastuszak
Nutritional Neuroscience|January 21, 2024
Low-carbohydrate diet as a nutritional intervention in a major depression disorder: focus on relapse preventionMichał Walaszek, Zofia Kachlik, Wiesław Jerzy Cubała
Journal of Clinical Medicine|January 10, 2026
Patients' Voices on Ketamine for Treatment-Resistant Depression: A Narrative Review of Qualitative PerspectivesMichał Walaszek, Wiesław Jerzy Cubała, Zofia Kachlik
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 17, 2026
Variability in AI-generated psychedelic definitions across major chatbotsZofia Kachlik, Wiesław Jerzy Cubała, Michał Walaszek
Therapeutic Advances in Psychopharmacology|July 1, 2026
Patient-centred education for ketamine and esketamine therapies in mood disordersZofia Kachlik, Wiesław Jerzy Cubała, Michał Walaszek
Frontiers in Pharmacology|August 28, 2024
Case report: Lichenoid eruption under immunotherapy with MK-4830 and pembrolizumab in a breast cancer patientZofia Kachlik, Izabela Błażewicz, Aleksandra Ciarka, et al.
Neuropsychopharmacology Reports|August 29, 2025
Nonresponse to Ketamine in Treatment-Resistant Bipolar DepressionZofia Kachlik, Wiesław Jerzy Cubała, Michał Walaszek, et al.
Therapeutic Advances in Psychopharmacology|February 3, 2026
Anhedonia nonresponse to short-term ketamine administration for treatment-resistant bipolar depressionZofia Kachlik, Wiesław Jerzy Cubała, Michał Walaszek, et al.
Journal of Affective Disorders|April 9, 2026
Clinical correlates of anhedonia non-response to ketamine in treatment-resistant depressionMichał Walaszek, Wiesław Jerzy Cubała, Zofia Kachlik, et al.
Pharmacological Reports : PR|April 30, 2025
Non-response to short-term ketamine use for treatment-resistant depressionMichał Walaszek, Wiesław Jerzy Cubała, Zofia Kachlik, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Journal of the European Academy of Dermatology and Venereology : JEADV|July 10, 2024
Comments on 'Characterization of patients with atopic dermatitis based on flare patterns and severity of disease: A Danish population-based study'Zofia Kachlik, Michał Walaszek, Michał Pastuszak
Nutritional Neuroscience|January 21, 2024
Low-carbohydrate diet as a nutritional intervention in a major depression disorder: focus on relapse preventionMichał Walaszek, Zofia Kachlik, Wiesław Jerzy Cubała
Journal of Clinical Medicine|January 10, 2026
Patients' Voices on Ketamine for Treatment-Resistant Depression: A Narrative Review of Qualitative PerspectivesMichał Walaszek, Wiesław Jerzy Cubała, Zofia Kachlik
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 17, 2026
Variability in AI-generated psychedelic definitions across major chatbotsZofia Kachlik, Wiesław Jerzy Cubała, Michał Walaszek
Therapeutic Advances in Psychopharmacology|July 1, 2026
Patient-centred education for ketamine and esketamine therapies in mood disordersZofia Kachlik, Wiesław Jerzy Cubała, Michał Walaszek
Frontiers in Pharmacology|August 28, 2024
Case report: Lichenoid eruption under immunotherapy with MK-4830 and pembrolizumab in a breast cancer patientZofia Kachlik, Izabela Błażewicz, Aleksandra Ciarka, et al.
Neuropsychopharmacology Reports|August 29, 2025
Nonresponse to Ketamine in Treatment-Resistant Bipolar DepressionZofia Kachlik, Wiesław Jerzy Cubała, Michał Walaszek, et al.
Therapeutic Advances in Psychopharmacology|February 3, 2026
Anhedonia nonresponse to short-term ketamine administration for treatment-resistant bipolar depressionZofia Kachlik, Wiesław Jerzy Cubała, Michał Walaszek, et al.
Journal of Affective Disorders|April 9, 2026
Clinical correlates of anhedonia non-response to ketamine in treatment-resistant depressionMichał Walaszek, Wiesław Jerzy Cubała, Zofia Kachlik, et al.
Pharmacological Reports : PR|April 30, 2025
Non-response to short-term ketamine use for treatment-resistant depressionMichał Walaszek, Wiesław Jerzy Cubała, Zofia Kachlik, et al.
Pageof 2